Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
Completed
- Conditions
- Pelvic Inflammatory Disease
- Registration Number
- NCT00783419
- Lead Sponsor
- Unity Health Toronto
- Brief Summary
A retrospective review of women who came through the ER at SMH with a pelvic inflammatory disease (PID) or tubo-ovarian abscess (TOA) between 1995-2005. They were looking at people with this diagnosis to determine how they were treated, whether as inpatient or outpatient and whether they were treated with drugs and how were these given and also did they develop an abscess.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 55
Inclusion Criteria
- women admitted to Emergency with pelvic-inflammatory disease or tubo-ovarian abscess from the year range: 1995-2000
Exclusion Criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Pelvic Inflammatory Disease progression to tubo-ovarian abscesses?
How effective are outpatient antibiotic regimens compared to inpatient care for PID management in clinical practice?
Which biomarkers correlate with abscess formation in Pelvic Inflammatory Disease patients?
What are the adverse event profiles associated with current standard-of-care treatments for tubo-ovarian abscesses?
How do combination therapies involving anti-inflammatory agents impact PID outcomes compared to monotherapy?
Trial Locations
- Locations (1)
St. Michael's Hospital
🇨🇦Toronto, Ontario, Canada
St. Michael's Hospital🇨🇦Toronto, Ontario, Canada